Genetic & Genomic MedicinemedRxivPreprint
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.
Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino…·Alessandra Larocca
This study identifies genomic and immune factors associated with resistance to anti-CD38 therapy in multiple myeloma patients.
3 citations